Tenderwize
Back to tender search

Non-exclusive discount agreement for Midazolam (ATC N05CD08) in Lower Saxony

AOK Niedersachsen. Die Gesundheitskasse.·Hannover, Germany·Deadline Apr 27, 2028 · 613 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V für die im Rahmen des Sprechstundenbedarfs in Niedersachsen verordnungs- und abgabefähigen Arzneimittel mit dem Wirkstoff Midazolam (ATC-Code (WHO): N05CD08).

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

50 / 100

Complexity

20 / 100

Risk factors

No estimated contract value or maximum framework value is available, making it difficult to assess revenue potential.

The notice states it is not a public procurement; legal challenges must be brought before social courts, not procuremen...

No procurement documents available

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jun 2028
  • Supply of Midazolam (ATC N05CD08) as pharmaceutical products under a non-exclusive discount agreement for outpatient care in Lower Saxony, Germany.
  • Participation is open to all pharmaceutical entrepreneurs meeting eligibility criteria on a first-come, first-served basis without competitive selection.
Show full summary

This is a non-exclusive discount agreement (open-house model) for Midazolam (ATC N05CD08) as pharmaceutical products for outpatient care in Lower Saxony, Germany, from 01.07.2026 to 30.06.2028. All eligible pharmaceutical entrepreneurs can join at any time (monthly) during the period. No selection is made; the notice is published for transparency. No estimated value is provided.

Risks

No estimated contract value or maximum framework value is available, making it difficult to assess revenue potential.

The notice states it is not a public procurement; legal challenges must be brought before social courts, not procuremen...

No procurement documents available

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur as defined in § 4 Abs. 18 AMG with respect to the offered medicinal products containing Midazolam.
  • Must have a seat in Germany, another EU member state, or an EEA state (§ 9 Abs. 2 Satz 1 AMG).
  • Local representatives are allowed only if they themselves are pharmaceutical entrepreneurs for the offered products.

Requirements may be incomplete.

Buyer

Location

Hannover, DEU

Identifier

AOK- Niedersachsen. Die Gesundheitskasse

Activity

Health

Lots (1)

LOT-0000

Non-exclusive discount agreement for Midazolam (ATC N05CD08) in Lower Saxony

Conclusion of a non-exclusive discount agreement according to § 130a Abs. 8 SGB V for the active ingredient Midazolam (ATC code: N05CD08) for outpatient care in Lower Saxony. Open-house model: no selection, all eligible pharmaceutical entrepreneurs can join. Contract duration: 01.07.2026 to 30.06.2028, with possible monthly joining and 6-week notice termination.

SuppliesFrameworkEU fundedElectronic submission

Location

DE929, Germany

Duration

Jun 2026 - Jun 2028

Category

Pharmaceutical products

Deadline

Deadline Apr 27, 2028

Procurement Details

Publication date
14 May 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
332947-2026

Similar tenders